Opportunistic testing ofBRCA1,BRCA2and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels-Reference-Cited by-同舟云学术

Opportunistic testing ofBRCA1,BRCA2and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels

Published:2019-04-15 Issue:10 Volume:145 Page:2682-2691
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Feliubadaló Lídia¹²³,López‐Fernández Adrià⁴,Pineda Marta¹²³,Díez Orland⁵⁶,Valle Jesús¹²³,Gutiérrez‐Enríquez Sara⁵^ORCID,Teulé Alex¹²³,González Sara¹²³,Stjepanovic Neda⁴⁷,Salinas Mónica¹²³,Capellá Gabriel¹²³,Brunet Joan¹⁸⁹,Lázaro Conxi¹²³,Balmaña Judith⁴⁷^ORCID,Campos Olga,Carrasco Estela,Cuesta Raquel,Darder Esther,Gadea Neus,Gómez Carolina,Grau Elia,Iglesias Silvia,Izquierdo Angel,Llort Gemma,Menéndez Mireia,Moles‐Fernández Alejandro,Montes Eva,Muñoz Xavier,Navarro Matilde,Ramon y Cajal Teresa,Sanz Judit,Solanes Ares,Stradella Agostina,Tornero Eva,Torres‐Esquius Sara,Tuset Noemí,Urgell Gisela,Velasco Angela,

Affiliation:

1. Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELLHospitalet de Llobregat Barcelona Spain

2. Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELLHospitalet de Llobregat Barcelona Spain

3. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Spain

4. High Risk and Familial CancerVall d'Hebron Institute of Oncology Barcelona

5. Oncogenetics GroupVall d'Hebron Institute of Oncology Barcelona Barcelona Spain

6. Molecular and Clinical Genetics Area. Hospital Vall d'HebronUniversitat Autonòma de Barcelona Barcelona Spain

7. Medical Oncology Department. Hospital Vall d'HebronUniversitat Autònoma de Barcelona Barcelona Spain

8. Hereditary Cancer ProgramCatalan Institute of Oncology, IDIBGI Girona Spain

9. Medical Sciences DepartmentSchool of Medicine, University of Girona Girona Spain

Funder

Carlos III Health Institute

Generalitat de Catalunya

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32304

Reference46 articles.

1. Application of Panel-Based Tests for Inherited Risk of Cancer

2. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

3. Counselling framework for moderate-penetrance cancer-susceptibility mutations

4. Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

5. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Open-Source Bioinformatic Pipeline to Improve PMS2 Genetic Testing Using Short-Read NGS Data;The Journal of Molecular Diagnostics;2024-08

2. Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population;2024-03-28

3. Roles of Matrix Metalloproteinases 2 and 9 in Uterine Leiomyosarcoma;Anticancer Research;2024-03-27

4. Use of multi-gene panels in patients at high risk of hereditary digestive cancer: Position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium;Gastroenterología y Hepatología (English Edition);2024-03

5. Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC);Current Problems in Cancer;2023-12